We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Homogeneous Assay Measures Small Dense LDL Cholesterol

By LabMedica International staff writers
Posted on 29 Dec 2010
A simple homogeneous assay has been developed to measure plasma concentrations of small dense-low density lipoprotein (SD-LDL). More...


A rapid assay suitable for autoanalyzers has been devised to measure the concentration of SD-LDL cholesterol in blood samples and is much easier to use than the complex methods that require special equipment and long assay times.

Scientists at the Showa University School of Medicine, (Tokyo, Japan), have identified suitable surfactants and phospholipases by screening for those selective for the SD-LDL fraction (density range: 1.044 kg/L - 1.063 kg/L) and for the dissociation of other lipoproteins, including large buoyant LDL (lb-LDL). They compared this technique with ultracentrifugal isolation of LDL subfractions and with heparin-magnesium precipitation assay for SD-LDL. They measured SD-LDL-C concentrations in 460 healthy, normolipidemic individuals. Small, dense LDL is a type of LDL cholesterol that is considered to be an emerging risk factor for cardiovascular disease. It is smaller and heavier than typical LDL cholesterol and can increase the risk of developing atherosclerosis.

The homogeneous method correlated excellently with ultracentrifugation for SD-LDL-C and exhibited within-run precision. The distribution of SD-LDL-C was skewed, and the central 95% of SD-LDL-C concentrations ranged from 0.24 to 0.88 mmol/L (9.4–34.0 mg/dL). The homogeneous assay SD-LDL-C results for 60 samples from healthy volunteers were compared with those obtained by ultracentrifugation. Serum samples were obtained from these individuals who had variable serum lipid levels; LDL-C range: 1.6–5.2 mmol/L (63–199 mg/dL); triglycerides range: 0.3–5.2 mmol/L (30–472 mg/dL), and high-density lipoprotein cholesterol: 0.9–2.5 mmol/L (35–97 mg/dL).

The authors concluded that the homogeneous assay allows reproducible measurement of SD-LDL-C within 10 minutes and appears promising in further investigations of the clinical significance of SD-LDL-C. The study was published in December 2010, in Clinical Chemistry.

Related Links:

Showa University



New
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
POC Immunoassay Analyzer
Procise DX
New
Thyroid Test
Anti-Thyroid EIA Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Accurate immunotherapy selection for esophageal and GEJ carcinomas depends on consistent PD-L1 assessment (credit: Adobe Stock)

FDA Approval Expands Use of PD-L1 Companion Diagnostic in Esophageal and GEJ Carcinomas

Esophageal and gastroesophageal junction carcinomas (GEJ) have a poor prognosis, with approximately 16,250 deaths in the United States in 2025 and a five-year relative survival of 21.9%.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.